Skip to main content
Log in

Effect of sodium ipodate and iodide on free T4 and free T3 concentrations in patients with Graves’ disease

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Graves’ hyperthyroid patients were treated daily for 10 days with 1 g sodium ipodate, a cholecystographic agent which exerts a blocking effect on the peripheral conversion of T4 to T3, or with 12 drops of saturated solution of potassium iodide (SSKI). Serum concentrations of free T4 (FT4) and free T3 (FT3) were measured before, during and 5 and 10 days after the administration of each drug. Sodium ipodate treatment induced a rapid decrement of serum FT4 concentrations which declined from 48.9 ± 6.6 pg/ml to 26.0 ± 2.7 pg/ml. In these patients serum FT3 concentrations declined from 12.4 ± 2.0 pg/ml to 2.5 ± 0.4 pg/ml. Ten days after sodium ipodate withdrawal, serum FT4 and FT3 concentrations returned to baseline values. In patients treated with SSKI serum FT4 concentrations declined from 51.1 ± 8.8 pg/ml to 11.3 ± 1.4 pg/ml and FT3 from 15.7 ± 2 pg/ml to 2.6 ± 0.3 pg/ml. Moreover, after therapy interruption serum free thyroid hormone concentrations returned to baseline values in these patients. Serum FT4 pattern during the study was not different between the two groups of subjects whereas serum FT3 concentrations were significantly lower in patients treated with sodium ipodate. These findings indicate that SSKI and sodium ipodate are effective in inducing a rapid decrement of serum free thyroid hormone concentrations. Therefore the employment of these drugs may be useful in the treatment of patients with thyroid storm and those undergoing thyroidectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brown J., Solomon D.H., Beall G.N., Terasaki P.I., Chopra I.J., Van Herle A.J., Wu S.Y. Autoimmune thyroid diseases. Graves’ and Hashimoto’s. Ann. Intern. Med. 88: 379, 1978.

    Article  Google Scholar 

  2. Wu S.Y., Chopra I.J., Solomon D.H., Bennett L.R. Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (oragraphin), an agent for oral cholecystography. J. Clin. Endocrinol. Metab. 46: 691, 1978.

    Article  PubMed  CAS  Google Scholar 

  3. Wu S.Y., Chopra I.J., Solomon D.H., Jonhson D.E. The effect of repeated administration of ipodate (oragrafin) in hyperthyroidism. J. Clin. Endocrinol. Metab. 47: 1358, 1978.

    Article  PubMed  CAS  Google Scholar 

  4. Wu S.Y., Shyh T.P., Chopra I.J., Solomon D.H., Huang H. W., Chu P.C. Comparison of sodium ipodate (oragrafin) and propylthiouracil in early treatment of hyperthyroidism. J. Clin. Endocrinol. Metab. 54: 630, 1982.

    Article  PubMed  CAS  Google Scholar 

  5. Emerson C.H., Anderson A.J., Howard W.J., Utiger R.D. Serum thyroxine and triiodothyronine concentrations during iodide treatment of hyperthyroidism. J. Clin. Endocrinol. Metab. 40: 33, 1975.

    Article  PubMed  CAS  Google Scholar 

  6. Braverman L.E. Is there a place for long term stable iodine in the treatment of Graves’ disease? In: Hamburger J.I., Miller J.M. (Eds.), Controversies in Clinical Thyroidology. Springer-Verlag, New York, 1981, p. 164.

    Google Scholar 

  7. Roti E., Robuschi G., Manfredi A., d’Amato L., Gardini E., Salvi M., Montermini M., Barilli A.L., Gnudi A., Braverman L.E. Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves’ disease. Clin. Endocrinol. (Oxf.) 22: 489, 1985.

    Article  CAS  Google Scholar 

  8. Robbins J., Johnson M.L. Theoretical considerations in the transport of the thyroid hormones in blood. In: Ekins R., Faglia G., Pennisi F., Pinchera A. (Eds.), Free Thyroid Hormones. Excerpta Medica, Amsterdam, 1979, p. 1.

    Google Scholar 

  9. Kramer C.Y. Extension of multiple range tests to group means with unequal number of replication. Biometrics 13: 307, 1956.

    Article  Google Scholar 

  10. Hamburger J.I. Is there a place for long term stable iodine in the treatment of Graves’ disease? In: Hamburger J.I., Miller J.M. (Eds.), Controversies in Clinical Thyroidology. Springer Verlag, New York, 1981, p. 159.

    Chapter  Google Scholar 

  11. Costa A. The use of X-ray contrast media in the treatment of hyperthyroidism. J. Endocrinol. Invest. 2: 461, 1979 (letter)

    Article  PubMed  CAS  Google Scholar 

  12. Wartofsky L., Ransil B.J., Ingbar S.H. Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis. J. Clin. Invest. 49: 78, 1970.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  13. Chopra I.J., Solomon D.H., Chopra U., Wu S.Y., Fisher D.A., Nakamura Y. Pathways of metabolism of thyroid hormones. Recent. Prog. Horm. Res. 34: 521, 1978.

    PubMed  CAS  Google Scholar 

  14. Kaplan M.M., Utiger R.D. Iodothyronine metabolism in rat liver homogenate. J. Clin. Invest. 67: 459, 1978.

    Article  Google Scholar 

  15. Silva J.E., Dick T.E., Larsen P.R. The contribution of local tissue thyroxine monodeiodination to the nuclear 3, 5, 3′-triiodothyronine in pituitary, liver and kidney of euthyroid rats. Endocrinology 103: 1196, 1978.

    Article  PubMed  CAS  Google Scholar 

  16. Felicetta J.V., Green W.L., Nelp W.B. Inhibition of hepatic binding of thyroxine by cholecystography agents. J. Clin. Invest. 65: 1032, 1980.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  17. Emanuele R., Robuschi G., Tagliaferri A., d’Amato L., Salvi M., Gnudi A., Manfredi A., Tecchio T., Roti E. Iodothyronine and thyrotropin concentrations after iodoamide administration for angiographic studies. La Ricerca 12: 589, 1982.

    CAS  Google Scholar 

  18. Kleinmann R.E., Sternthal E., Starobin O., Braverman L. E. Cardiac catheterization dye does not affect serum thyroid hormone concentrations or TSH secretion. Cathet. Cardiovasc. Diagn. 8: 261, 1982.

    Article  PubMed  CAS  Google Scholar 

  19. Grayson R.R. Factors which influence the radioactive iodine thyroidal uptake test. Am. J. Med. 28: 397, 1960.

    Article  PubMed  CAS  Google Scholar 

  20. Burgi H., Wimpfheimer C., Burger A., Zaunbauer W., Rösier H., Lemarchand-Beraud T. Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents. J. Clin. Endocrinol. Metab. 43: 1203, 1976.

    Article  PubMed  CAS  Google Scholar 

  21. Beng C.G., Wellby M.L., Symons R.G., Stuart S., Marshall J. The effect of ipodate on the serum iodothyronine pattern in normal subjects. Acta Endocrinol. (Kbh.) 93: 175, 1980.

    CAS  Google Scholar 

  22. Sharp B., Reed A.W., Tamagna E.I., Geffner D.L., Hershman J.M. Treatment of hyperthyroidism with sodium ipodate (oragraphin) in addition to propylthiouracil and propranolol. J. Clin. Endocrinol. Metab. 53: 622, 1981.

    Article  PubMed  CAS  Google Scholar 

  23. Wartofsky L. Low remission after therapy for Graves’ disease: possible relation of dietary iodine with antithyroid therapy results. JAMA 226: 1083, 1973.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robuschi, G., Manfredi, A., Salvi, M. et al. Effect of sodium ipodate and iodide on free T4 and free T3 concentrations in patients with Graves’ disease. J Endocrinol Invest 9, 287–291 (1986). https://doi.org/10.1007/BF03346928

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346928

Key-words

Navigation